ID: MRFR/MED/0538-HCR | 115 Pages | Published By Rahul Gotadki on March 2023
The Surgical Stents Market is expected to reach USD 20,437.3 Million by 2030 at 9.8% CAGR during the forecast period 2022-2030.The stent is a small, flexible metal or plastic tube that are inserted into the vessels or duct to keep the passageway open. Different types of materials like metal, standard polymer, and biodegradable polymer are used for the preparation of the surgical stents. According to the WHO (2015), more than 35% of the total global population was suffering from major or minor cardiovascular complications; and in 2014, globally 39% of adults aged 18 years and over were overweight whereas, 13% were obese. Thus, increasing prevalence of diabetes and obesity have increased the risk of urinary tract failure. Major driving factors for the growth of the market: Increasing prevalence of cardiovascular diseases, rising diabetic & obese population and rapid development in the technology. Moreover, rising healthcare expenditure, increasing geriatric population, and changing lifestyle have fueled the growth of the market. However, higher cost of surgeries and risk of infection may hinder the growth of the market during the forecast period 2017-2013.
Study Objectives:
Intended Audience
Figure 1- Surgical Stents Market, By Application, 2016 (%)
Â
Source- Annual reports, press release, white paper, company presentation
Key Players for Surgical Stents Market
Some of the major key player for the market are STI Laser Industries, Ltd (Israel), ELLA - CS, s.r.o. (Czech Republic), Boston Scientific Corporation (US), Laserage Technology corporation (US), amg International GmbH (Germany), Abbott (US), Angiocare (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun Melsungen AG (Germany), Medtronic (US), Amaranth Medical, Inc (US), Arterial Remodeling Technologies (US).
Segmentation
The surgical stents market is segmented into types, type of materials, application, and end users. On the basis of types, the surgical stents market is segmented: cardiac stents, urinary stents, biliary stents, esophageal stents, prostatic stents and other. Cardiac stents are further segmented: self-expanding stents, balloon expanding stents, bio-engineered stents, dual therapy stents, artery stents, drug eluting stents and other. Urinary stents are further segmented: open end stents, double pigtail stents, closed end stents and multi loop stents. On the basis of materials, the market is segmented: metal, standard polymer, and biodegradable polymer. On the basis of applications, the market is segmented into cardiac diseases, urinary tract diseases, and others. On the basis of end users, the market is segmented into hospital, clinics, and others.
Regional Analysis
America dominates the surgical stents market owing to an enormous number of the patient suffering from cardiac and renal diseases. Additionally, well-developed healthcare sector and higher healthcare expenditure have supported the growth of the market in this region. Europe accounts for the second largest market followed by Asia Pacific. Asia Pacific is the fastest growing region in the surgical stents market due to the presence of huge patient population base and rapidly developing economies.
Market Assessment
Source- World Health Organization (WHO), white paper, company presentation, American Heart Association, National Institutes of Health, The National Institute of Diabetes and Digestive and Kidney Diseases, Centres for Disease Control and Prevention, Annual reports
The report for the surgical stents market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected Surgical Stents Market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Report Attribute/Metric | Details |
---|---|
Market Size | 2030: USD 20,437.3 Million |
CAGR | 9.8% (2022-2030) |
Base Year | 2021 |
Forecast Period | 2022-2030 |
Historical Data | 2020 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Types, Type Of Materials, Applications and End Users |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | STI Laser Industries, Ltd (Israel), ELLA - CS, s.r.o. (Czech Republic), Boston Scientific Corporation (US), Laserage Technology corporation (US), amg International GmbH (Germany), Abbott (US), Angiocare (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), B. Braun Melsungen AG (Germany), Medtronic (US), Amaranth Medical, Inc (US), Arterial Remodeling Technologies (US). |
Key Market Opportunities | Rising healthcare expenditure and increasing geriatric population |
Key Market Drivers |
|
The Surgical Stents Market would be hampered by the high cost of products.
The end users are clinics, hospitals, and others.
The Americas would dominate the Surgical Stents Market.
The American Surgical Stents Market would gain from high expenditure in the market and well-developed healthcare sector.
The Asia Pacific market would move forward with the fastest CAGR.